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ABSTRACT 
 
Purpose of the study 
The main purpose of the study was to investigate the antiretroviral drug adherence of patients on 
government HAART regimen while being hospitalized at Dr. George Mukhari hospital in medical 
wards and level one ward. Ensuring high levels of adherence to antiretroviral treatment is a priority in 
managing patients with AIDS. 
 
Research Design 
Qualitative and quantitative data was collected prospectively. Data was collected through interviewing 
patients and registered nurses using structured questionnaires. Doctors’ clinical notes from the 
participant’s (patients) files were audited to understand the real gaps in failing to support the patients 
with adherence to their treatment. 
 
Findings 
In investigating the antiretroviral treatment drug adherence of hospitalized patients, two indicators 
were used: 
 The percentage of patient’s drug adherence level. 
 The level of support that is given by registered nurses and doctors to support the patients in 
maintaining their adherence to treatment while admitted. 
The research findings from the 25 participants revealed that 28% of patients had >95% adherence level 
and 72% of patients had <95% adherence level. The level of support from the doctors and registered 
nurses was poor, there was no commitment. These findings suggest that further studies are needed to 
improve the adherence level of patients on antiretroviral treatment. 
 
Conclusions 
Adherence to antiretroviral treatment is a powerful predictor of survival for individual living with HIV 
and AIDS. Factors that contributed to non-adherence should be attended to without delay.  
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OPSOMMING 
 
Doel van die studie 
Die doel van die studie was om te bapaal of pasiënte voldoen aan die regering se “HAART-regime” 
wat Anti-retrovilare (ARV’s) ontvang, gehospitaliseerd te Dr. George Mukhari hospital.  Die 
voldoening aan die toediening van ARV- behandeling is prioriteit in die behandeling en bevording van 
pasiënte met VIGS.   
 
Studie Ontwerp 
Kwalitatiewe en kwantitatiewe data was prospektief ingesamel. Data was ingesamel deur 
onderhoudvoering met pasiënte en geregistreerde susters, deur gebruik te maak van gestruktureerde 
vraelyste. Kliniese notas gemaak deur dokters in die betrokke pasiënt-leers is ook bestudeer om die 
probleemareas vas te stel, waar toediening van ARV- behandeling nie voldoende plaasgevind het nie.  
 
Bevindinge 
Twee indikatore is gebruik om te bestudeer of voldoende toediening van ARV-behandeling plaasvind.  
 Die persentasie van pasiënte wat wel voldoen aan korrekte ARV–behandeling. 
 Die vlak van ondersteuning ontvang deur geregistreerde susters en mediese dokters in die 
toediening van ARV- behandeling. 
Die navorsingsresultale toon die volgende van die studiegroep (=25): 
 28% : >95% voldoende toediening van ARV- behandeling. 
 72% : <95% voldoende toediening van ARV- behandeling. 
 
Die vlak van ondersteuning ontvang deur susters en mediese dokters was swak. Die bogenoemde 
bevindinge toon dat verdere studies nodig is om die vlak van voldoende toediening van ARV–
behandeling te bevorder en te verbeter. 
 
Gevolgtrekking 
Voldoende toediening van ARV–behendeling is ‘n sterk voorspeller vir die oorlewing van individue 
met MIV en VIGS. Faktore wat bydrae tot onvoldoende toediening van ARV–behandeling moet 
aangespreek word. 
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OPERATIONAL DEFINITION  
 
It is important to define the terms that are going to be measured and must be defined in the context of 
the study. 
Adherence – Adherence means that treatment is taken according to a treatment plan designed in 
consultation with the patient and involves taking: 
 The recommended dose 
 at the recommended time 
  in the recommended way 
 
In order for one to be adherent, a client at least should not miss more than three doses in a month. 
Adherence rate of 95% must be sustained to maintain control over viral load, build the immune system 
and prevent the development of resistance to the drug (Adherence Network Group, 2006:27). 
 
Adherence Supporter – This is support in the form of information, discussion, encouragement and 
motivation, provided by anyone in the patient’s life who plays a supportive role. This could include a 
doctor, nurse, dietician, pharmacist, treatment assistant, family member, partner or a friend [buddy] 
(Adherence Network Group, 2006:29). 
 
Adherence Counseling – T his is counseling provided to a person who starting ART, or on ART, to 
assist them to make choices that support their treatment and enable them to adhere to the medication. 
This counseling is ideally provided by a person who has been trained in HIV/AIDS counseling skills 
and in adherence counseling (Adherence Network Group 2006:29). 
 
Counseling – HIV/AIDS counseling may cover a wide variety of issues, example, substance abuse, 
mental health problems, preparation for death, medication and treatment approaches, job 
discrimination, financial needs, prenatal care, child care, family dynamics, and homelessness. This 
may include counseling from licensed professionals such as physicians, pharmacists, and 
psychologists or social workers and community members.  
 
In the field of HIV/AIDS, counseling can be divided into categories such as: 
Stellenbosch University  http://scholar.sun.ac.za
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 ARV adherence counseling which focuses on ensuring that  the clients  follow an ARV treatment 
regimen which has been designed for them in a consultative partnership  between the client and the 
health care worker or counselor. This type of counseling includes explaining to the client the need 
to follow the prescribed instructions and supporting them in taking the recommended dose, at the 
recommended time, in the recommended way, that is, the role of the counselor is to promote and 
sustain adherence, as well as ascertain what factors might be preventing adherence and find 
solutions. 
 Lay counseling which is commonly in the form of support from a caring person in the community. 
Lay counselors provide information such as where patients can receive ARV treatment, on 
improving their nutrition and on prevention. 
  
DOT (Directly Observe Therapy) – A treatment strategy in which a health care provider or other 
observer watches a patient takes each dose of a drug. This strategy is used with diseases like 
Tuberculosis and HIV infection, where adherence is important for effective treatment and to prevent 
emergence of drug resistance (PIEGO, 2004). 
 
Patient - in the context of this study, a patient refers to a hospitalized HIV positive person who is on a 
S.A. government antiretroviral therapy regimen. 
 
Doctor - Refers to a medical practitioner who is registered with the Health Professional Council of 
South Africa and legally qualifies to practice medicine and surgery. 
 
Level one ward - Wards that fall under Family Practice 
Family practice deals with primary health care conditions. 
Primary health care conditions do not fall under tertiary conditions. 
 
Antiretroviral Therapy [ART] – It involves the use of antiretroviral drugs to suppress replication of 
HIV virus in the body and its destruction of the immune system. ART is also sometimes referred as 
antiretroviral treatment, HIV therapy or antiretroviral drugs (Adherence Network Group 2006). 
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Triple therapy – Triple therapy involves the use of three types of drugs for treating (NT curing) HIV. I 
n 1988, mono-therapy (one drug) in the form of AZT was used to delay the onset of AIDS. Later on, 
dual therapy (two drugs) was seen to be better than mono - therapy, until triple therapy or combination 
drugs were produced. 
 
Triple therapy is also known as Highly Active Antiretroviral Therapy (HAART). Combination therapy 
for HIV infection has led to decreased mortality rates and more effective long – term control of the 
disease (Adherence Network Group 2006). 
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CHAPTER 1: OVERVIEW OF THE STUDY 
 
1.1 INTRODUCTION 
 
Antiretroviral therapy started in the late 1980’s with the introduction of the nucleoside reverse 
transcriptase inhibitor zidovudine [AZT]. The benefits were not sustained due to the development of 
resistance. In the early 1990’s dual therapy was introduced and resulted in longer duration of benefit, 
again resistance developed within a few years. In the mid 1990’s more powerful drugs like protease 
inhibitors [PI’s] and the non- nucleoside reverse transcriptase inhibitors [NNRTI’s] were developed. 
That justified the use of the concept HAART [FPD 2004]. 
 
Since then the accessibility of HAART has brought hope and has improved the quality of life to HIV 
positive patients. The South African government started rolling out comprehensive HIV/AIDS care, 
management and treatment in April 2004. 
 
There is a common agreement amongst the clinicians that to achieve an undetectable viral load and 
prevent the development of drug resistance a person on HAART need to take at least 95% of the 
prescribed doses on time (Castro, 2005). It is critical that patients on HAART are monitored closely to 
maintain the blood levels that could sustain the patient, and achieve improved immunity system. 
Adherence to medication is critical for maintaining or improving health status. This is evident for 
persons living with HIV, as adherence to HAART predicts both health status and failure success with 
antiretroviral therapy (ART: Ho et al; 1995). 
 
Adherence to demanding antiretroviral regimens requires substantial support and monitoring. Effective 
approaches to promote and improve patient adherence to antiretroviral therapy are the focus of 
intensive, time-consuming research (Simoni, et al; 2003). The study will be helpful to endorse the 
support needed by patients when admitted in the hospital to take treatment as scheduled. 
While full adherence to antiretroviral therapy has not been completely achieved even in developed 
countries, high adherence is a critical goal in sub-Saharan Africa, which has been hit by a catastrophic 
pandemic of HIV infection and where treatment often is a privilege of life. Little is known about 
Stellenbosch University  http://scholar.sun.ac.za
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adherence to antiretroviral therapy in Africa (Meichernbaum et al; 1997, Eron et al; 2000; Golin et al; 
2002; Tuldraand et al; 2003). 
 
Adherence plays a critical part in the success of HIV/AIDS treatment plan and can jeopardize expected 
treatment outcomes. Such “perfect” adherence poses various challenges to the patient, including 
lifelong pill taking, pill burden, frequent dosing intervals and food restrictions (Jude and Nwokike, 
2005). 
 
The challenges were of concern when Botswana started rolling-up ARV’s. The level of understanding 
the complex of HAART by Africans was cited. Adherence was understood from the chronic medicine 
compliance (example, hypertension and diabetes). It is now evident that ARV adherence is more 
demanding because the patient is centered, it is up to the patient to see her/his quality of life improves. 
The limited number of ARV regimen available in South Africa plays a major threat to the 
sustainability of treatment if the patient does not adhere to the treatment plan. 
 
1.2 BACKGROUND OF THE PROBLEM 
 
The epidemic of human immunodeficiency virus (HIV) acquired immunodeficiency syndrome (AIDS) 
is the world’s biggest challenge. It is alarming that South Africa has the world’s highest single 
HIV/AIDS case load, with more than five million of South Africa’s 45million people infected with 
HIV. South Africa is currently experiencing one of the most severe AIDS epidemics in the world. At 
the end of 2007, there were approximately 5,7million people living with HIV in South Africa, and 
almost 1,000 AIDS deaths occurring every day (South Africa Journal Epidemiology Infection Control, 
2008; 20). Taking into consideration the magnitude of the epidemic, it is extremely critical that 
patients started on antiretroviral treatment adhere to their treatment plan. 
 
1.2.1 HIV AND AIDS IN South Africa 
 
HIV and AIDS is one of the main challenges facing S.A. today. It is estimated that of the 39,5 million 
people living with HIV world while in 2006,more than 63% were from sub – Saharan Africa. In 2005 
about 5,54 million people were estimated to be living with HIV in South Africa, with 18.8% of the 
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adult population[15 – 49 years] and about 12% of the general population affected (South Africa DOH, 
2006). 
 
To address the HIV epidemic challenge, the DOH has come up with the HIV and AIDS and STI 
Strategic Plan for South Africa 2007 – 2011 [NSP] which flowed from the National Strategic Plan of 
2000 – 2005, the Operational plan for Comprehensive HIV and AIDS Care, Management and 
Treatment [CCMT] as well as other HIV and AIDS strategic frameworks developed for government 
and sectors of civil society in the past five years. The DOH was mandated by the Deputy President, 
Mrs. Phumzile Mlambo -   Ngcuka in 2006 to lead the process.  
 
The NSP in not a plan for the health sector alone, it involves all agencies working with HIV and AIDS 
in South Africa. Practically it seeks to strengthen and improve the efficiency of existing services and 
infrastructure and introduce additional interventions based on recent advances in knowledge. [DOH, 
NSP, 2006]. 
 
One of the NSP target goals is to give 80% of the people eligible to ARV’s by 2011. 
South Africa started rolling out ARV’s in April 2004. 
 
1.2.2 HEALTH SYSYTEMS IN SOUTH AFRICA 
 
The implementation of the National HIV and AIDS Care and Treatment programme within the 
existing programme and service point is directed through Provincial Health Department. Each 
province is allocating a budget specifically for: 
 Antiretroviral drugs(drug procurement) 
 Diagnostic monitoring of patients on HAART through the laboratory. 
 Human resource for antiretroviral site (South Africa HIV and AIDS Operational Plan, 2003:234 & 
247). 
 
South Africa’s health system consists of a large public sector and a smaller but fast growing private 
sector. The basic primary health care is offered free by the government and those that can afford resort 
to the private sector. 
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The WHO framework, divides health systems into three objectives (goodness, fairness & 
responsiveness) and a set of functions (delivering services, creating resources and stewardship) 
required to achieve these objectives. This framework is appropriate for a classic service delivery 
intervention such as HIV treatment. Strengthening health systems is the key goal in accelerating ARV 
treatment and strengthening adherence programmes (Schneider et al; 2004:4-29). 
 
1.2.3 SOUTH AFRICAN RECOMMENDED ANTIRETROVIRAL TRERAPY REGIMEN  
 
Regimen 1a Regimen 1b Regimen 2 
Staudinger(d4t) Staudinger Zidovudine(AZT) 
Lamivudine(3TC) Lamivudine Didanasone(ddl) 
Efavirenz(EFV)(NVP)(AZT) Nevarapine Lopinavir:/Ritonavir 
   
 
1.2.4 ENTRY POINTS FOR ELIGIBILITY TO ARV THERAPY 
 
 HIV positive results 
 CD4 count < 200 
 Stage 4 HIV positive patients[according to WHO staging] 
 Three adherence counseling to be attended before receiving HAART. 
 
Adherence counseling is provided to HIV positive patients before starting ART or who is already on 
ART, to assist them to make choices that support their treatment and enable them to adhere to the 
medication (Meyersfeld, Hamilton and Lazarus, 2006). 
 
1.2.5 THE PRIMARY GOALS OF ART 
 
 Maximal and suppression of the viral load. 
 Restoration and/or preservation of immunological function. 
 Improvement of quality of life. 
 Reduction of HIV related morbidity and mortality and its destruction of the immune system. 
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The patient should commit herself/himself to this lifetime treatment. It is imperative that the patient 
adhere to the HAART to maintain long term health benefits, to suppress replication of HIV in the body 
and to avoid development of drug resistance. The treatment criteria require the patient to have a 
treatment supporter who will remind her/him about taking treatment as expected. The treatment 
supporter is not an exclusive criterion (South Africa DOH, 2004). That is why it is critical that the 
patient is provided with a comprehensive plan to support adherence. 
 
These goals are achieved by suppressing viral replication for as long as possible by using tolerable and 
sustainable treatment for an indefinite period of time. With prolonged viral suppression the CD4 
lymphocyte count usually progressively increases with partial restoration of pathogen-specific immune 
function, dramatically reducing the morbidity and mortality associated with HIV infection (S.A. 
Journal of HIV Medicine, 2008). 
 
1.2.6 PUBLIC PRIVATE PARTNERSHIP IN ACCELERATING THE ACCESS TO 
ANTIRETROVIRAL TREATMENT IN SOUTH AFRICA  
 
The South Africa’s HIV and AIDS Care, Treatment and Management programme was designed for 
implementation in the public sector. It is acknowledged that the HIV virus does not observe national 
borders. The South Africa government committed itself to ensure that the standards it establishes for 
quality and accreditation in the public health sector are replicated in the private sector. 
Pharmacovigilance, monitoring and evaluation and research agendas, are coordinated with the private 
sector to ensure a successful national AIDS treatment. 
 
Private NGO’s and companies do assist the government with community mobilization, support 
programmes, education and communications programmes, also programmes to integrate education and 
prevention with treatment and other health promoting activities. Non-Governmental Organization 
(example, USAID) enters into a Memorandum of Understanding contract agreement with the 
government (S. A. Operational Plan, 2003:235). 
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1.3 PROBLEM STATEMENT 
 
Antiretroviral drug non-adherence from patients that are on highly active antiretroviral 
treatment [HAART] and are hospitalized to medical wards and level one wards in Dr. G. 
Mukhari hospital is a great concern that needs to be investigated. 
Dr G. Mukhari hospital is a tertiary level hospital under University of Limpopo [MEDUNSA 
campus].Treatment of antiretroviral [ARV] treatment to eligible HIV positive patients started in July 
2004. The hospital is receiving patients from 16 surrounding primary health care sites. Presently there 
are 6000 patients that have been started on ARV treatment. 
 
The greatest challenge with patients receiving ARV is adherence to their treatment irrespective of the 
situations they find themselves in. Patients that are admitted [hospitalized] in the health institutions 
depend mostly on the health care workers to remind them to take their treatment as scheduled or  
health care workers to take over when their too sick to help themselves. There is a concern from 
patients, lay counselors and patient’s relatives about patients that are not receiving support from health 
care worker [HCW] in ensuring that hospitalized patients adhere to their antiretroviral treatment as 
expected. Health care workers should act as treatment supporters to in-patients. 
 
According to [South Africa DOH, 2004], ideal adherence means a patient must take more than 95% of 
their doses [that is missing less than 3doses in a month] It is imperative that patients adhere to their 
treatment because if a patient is taking less than 95% of their ARV doses, they are at risk for 
developing viral resistance and ultimately biological failure. The doctors and registered nurse in 
charge of departments must play a key role in ensuring that patients receive treatment as expected 
while they are hospitalized.  
 
1.4 PURPOSE OF THE STUDY 
 
The main purpose of this study is to investigate ARV drug adherence of patients on government ARV 
regimen while being hospitalized at DGMH in medical wards and level one ward. 
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1.5 OBJECTIVES OF THE RESEARCH 
 
These objectives will guide the research to: 
 To measure the levels of adherence. 
 To explore the factors associated with non – adherence among hospitalized patients receiving 
HAART. 
 To measure the level of support given by health care workers to patients receiving HAART while 
admitted. 
 
1.6 RESEARCH QUESTION 
 
This research study will answer the following questions: 
 What happens when a patient is admitted to medical wards and level one wards and is on ARV’s in 
Dr. George Mukhari hospital? 
 How far the doctors and registered nurses support and contribute to the sustainability of ARV drug 
adherence for patients under their care. 
 
1.6.1 WHY IT IS IMPORTANT TO FIND ANSWERS TO THIS RESEARCH QUESTION? 
 
 To improve adherence to patients on HAART while being hospitalized. 
 To find out whether patients on HAART disclose their treatment to health care workers for the 
purpose of continuity of treatment, also for the patients to find out how to go about taking their 
treatment without being discriminated. 
 To empower health care workers in managing patients with HIV and AIDS, also to those that 
are already on HAART. 
 
The reason for me to choose this problem is through the concern of the community that the health care 
workers are not honouring the Patient’s Rights Charter. 
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1.6.2 SOUTH AFRICA   PATIENT’s RIGHTS CHARTER 
EVERY PATIENT HAS A RIGHT TO: 
 
1. A healthy and safe environment. 
2. Participate in decision making’ 
3. Access to health 
Everyone has the right of access to health care services that include: 
 receiving timely emergency care 
 treatment and rehabilitation 
 provision for special needs[in the case of newborn infants,children,pregnant women, the aged, 
disabled persons, patients in pain, persons with HIV or AIDS patients] 
 counseling[without discrimination, coercion or violence on matters such as reproductive health, 
cancer or HIV/AIDS] 
 palliative care[that is affordable and effective in cases of incurable or terminally illness] 
 a positive disposition 
 healthy information 
4. Knowledge of one’s health insurance/medical aid scheme 
5. Choice of health services 
6. Be treated by a named health care worker 
7. Confidentiality and privacy 
8. Informed consent 
9. Refusal of treatment 
10. Be referred for a second opinion 
11. Continuity of care 
12. Complain about health services [everyone has the right to complain about health care 
services and have such complaints investigated and to receive a full response on such 
investigation (S.A. Department of Health, 2003). 
 
1.7 SIGNIFICANCE OF THE STUDY 
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The research study will empower health care workers with knowledge in managing patients with 
HIV/AIDS and assisting them to correlate their knowledge with practice. This study will give hope to 
HCW that HIV/AIDS is manageable, as long as the patient takes treatment as scheduled. This can be a 
motivator to the HCW to go and test for HIV. 
Much as the S.A. government has developed guidelines in management of HIV/AIDS (DOH, 2004); 
there are still challenges that require S.A. health professionals to engage in researches regarding their 
own situations. The study will add understanding of developing national core standards in 
management of HIV/AIDS with an aim of improving the quality of care of people living with 
HIV/AIDS. Presently there are no national operating standards in public institutions regarding 
management of patients on HAART.Health care workers become confused because a patient receiving 
HAART from a private doctor cannot be prescribed ART in a public institution; this becomes 
questionable in terms of maintaining adherence. 
 
1.8 CONCLUSION 
 
The first chapter dealt mainly with the study problem, background the reason behind conducting this 
research study. The study definitely needs to be explored further as admissions of patients on HAART 
increases. 
 
The next chapter will discuss the literature reviewed regarding ANTIRETROVIRAL DRUG 
ADHERENCE. 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 INTRODUCTION 
 
Literature review will guide me as to whether the problem that I have identified is already researched 
or not. Information that I gathered, researched ADHERENCE from another angle and I will be 
approaching it from the angle of treatment interruption of patients that are hospitalized (Struwig and 
Stead, 2004). 
 
The general purpose of the library search is to gain an understanding of the current state of knowledge 
about the selected topic. Review of the literature will tell you whether the problem you have identified 
has already been researched and may guide you in designing the study (Christensen, 2007). 
 
Highly active antiretroviral therapy has revolutionized the treatment of AIDS patients, leading to 
substantial reductions in the HIV – related morbidity and mortality. HAART provision requires careful 
and frequent monitoring to prevent and manage interactions, to avoid adverse effects and suppress 
development of HIV – 1 antiretroviral associated resistance. Studies in ambulatory patients have 
clearly demonstrated that greater expertise in HIV care provision lead to patient outcomes and reduce 
healthcare expenditures (Pharmacother, 2008). Following up from this information, it is critical that 
hospitalized patients on HAART adhere to their treatment and receive full support from health care 
workers so that the number of stay is reduced and patient’s health improves in time and health care 
costs are reduced. The WHO, (2003), convened a working group to review the literature around long 
term adherence within a chronic disease context. The long-term adherence was defined as “the extent 
to which a person’s behavior –taking medication, following a diet executing lifestyle changes”. 
 
2.2 ADHERENCE 
 
There is no universally accepted definition of adherence. With respect to HIV/AIDS care specifically, 
“medication adherence” has been defined as the ability of the person living with HIV/AIDS to be 
involved in choosing, starting, managing and maintaining a given therapeutic combination regimen to 
control viral (HIV) replication and improve immune function (Simon, et al; 2003). 
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In terms of ARV therapy it means adhering to the prescribed regimen. 
 For the patient it means taking all pills and doses in accordance with the prescription. 
It also means: 
 Maintaining certain life style like practicing safe sex. 
  Maintaining a healthy diet  
  Exercises and adequate sleep 
 Attending follows up appointments 
 Collecting prescribed treatment (South Africa DOH, 2004). 
 
The term adherence has been adopted by the World Health Organization [WHO], it was preferred 
because it gives an element of patient choice. 
Studies have shown greatly improved prognosis with correct adherence. 
The level of adherence is entirely patient driven factor. 
Adherence is considered to be the cornerstone of successful ARV therapy. It also represents the 
patient’s and the health care professional’s commitment to fighting HIV infection and achieving long 
term suppression of the virus (South Africa DOH, 2004). 
 
Directly Observed Treatment [DOT] has been used with good results in one study in the United State 
Department of Correctional Services in the treatment protocol of HIV. In South Africa DOT is used in 
the treatment of Tuberculosis and our cure rate is 60%. It is assumed that therefore DOT in the 
treatment of HIV would not work in South Africa adding to the fact that stigmatization is still rife. 
 
 Adherence is a problem even in developing countries. In United Kingdom ART [antiretroviral 
therapy] guidelines are being formulated to increase adherence levels. 
South African indicators show [Courtesy of MSD and Treatment Helpline] that: 
 
 Twenty eight percent [28%] of patients do not inform anybody of their condition 
outside the doctor’s surgery. 
  Fifty four percent [54%] have only informed their partners or spouses 
 Only 18% have any major family support 
No real in depended studies on adherence levels have been done in South Africa. 
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Recent studies in Europe show that without any support [The Athena Study]  
53% will be 100% compliant and    47% will be non- compliant. 
 
According to Treatment Helpline Direct in South Africa shows that:  
 Five percent [5%] of patients will take their pills according to doctor’s prescription. 
  Ninety five [95%] of patients will not take all their medication precisely as directed by 
their doctor. 
Ideal adherence means a patient must take more than 95% of their doses [that is, missing less than 3 
doses in a month]. Pill counting should be done with every visit to assess the adherence rate; this 
exercise is not practical in a heavy clinic with many patients. 
 
Measuring accurate adherence to therapy is difficult. Self reporting by patients will be weighed, if the 
patient admits to missing doses that is helpful. Doctor’s estimates of patient’s adherence have been 
shown to be very unreliable (FPD, 2004). 
Patients will be measured also using the “Categories of Non – Compliance” score board (FPD, 2005). 
 
2.3   ART ADHERENCE IN SOUTH AFRICA  
 
South African ART guidelines stress the adherence to ART as important to maintain long term health 
benefit and avoid development of drug resistance. Ideal adherence means a patient must take more 
than 95% of their doses (i.e. missing less than 3 doses in a month).If a patient is taking less than 95% 
of their doses, they are at risk for developing viral resistance and ultimately virological failure. 
Role of the health care team: 
 
There is evidence that there are fewer adherences as time progresses. Thus, monitoring and ongoing 
support of adherence is essential. 
 New diagnoses or symptoms can influence adherence 
 A trusting relationship between the patient and members of the health care team is essential. 
 Optimal adherence requires full participation by the health care team: patient, family members 
and the community. 
 Every patient interaction is an opportunity for reinforcement. 
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 Supportive and non – judgmental attitudes and behaviors will encourage patient honesty 
regarding adherence and problems. 
 
Strategies to promote adherence 
 
 Spend time with the patient. Explain the goals of therapy and need for adherence as many 
times as is necessary. 
 Consider monitoring of medications such a cotrimoxazole or by an alternative method prior to 
ART initiation. 
 Negotiate a treatment plan that the patient can understand and to which he/she commits. 
 Encourage disclosure to family or friends who can support the treatment plan. 
 Inform patient of potential side effects- severity, duration and coping mechanisms. 
 Establish “readiness” to take medications before ART initiation. 
 Provide adherence tools where available: written calendar of medications, pill box. 
 Encourage use of alarms, pages or other available mechanical aids for adherence. 
 Avoid adverse drug interactions. The patient must disclose any over- the – counter drugs and 
traditional medicines. Other medications as well as some traditional medicines cannot be taken 
concurrently with ART because they may cancel each other out or may lead to unacceptable 
adverse effects. 
 Anticipate, monitor and treat side effects. 
 Include adherence discussions in support groups. 
 Develop links with community based organizations to support adherence. 
 Encourage links with support groups. 
 Create links with patient advocates (S.A. Dept of Health, 2004). 
 
2.4 NON-ADHERENCE 
 
Non-adherence means not following the treatment plan. 
Examples of non-adherence are: 
 Incorrect doses(e.g. too little/too much medication, taken in the wrong way) 
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 Missed doses(e.g. due to changes in routine, travelling or forgetfulness) 
 Delayed doses(that is, not taking the dose on time) 
 Failing to follow guidelines(e.g. social pressure or misinformation) 
 Experimenting with dosing( example, trying unapproved once-daily regimens) 
 Drug holidays( example, transient aversion to taking pills) 
 
The results of non-adherence are the possible development of drug resistance. 
Almost all patients will be non-adherent at some stage. Adherence tends to decline over time 
(Adherence Network Group, 2006). 
 
Castro (2005) looked at adherence s biological and social processes that changes with time. Several 
studies have tried to predict the causes of non-adherence in order to reduce the number of missed 
doses. They concluded that methodologically there is  growing agreement that patients’’ self 
assessment of adherence-through interviews or self- administered questionnaires show significant 
correlation with viral load tests, where-as estimations by their health care providers often lead to 
invalid results. This correlation is critical to my research study because patient’s information will 
be validated… against nurses and doctors clinical information. There is a need to research 
adherence while patients are hospitalized based on the information found on this study,  
 
WHAT HAPPENS IF ARV’s ARE NOT ADHERED TO? 
 
 Resistance to antiretroviral agents. 
 Failure to suppress viral replication. 
 Breakdown of the immune system. 
 Increased risk of opportunistic infections. 
 Increase risk of Kaposi’s sarcoma and other AIDS – related cancer. 
 An increasingly poor quality of life and shortened lifespan (FPD, 2005:216). 
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2.5 ADHERENCE versus COMPLIANCE 
 
COMPLIANCE – The extent to which the patient’s behavior (taking medication, following dates or 
making other lifestyle changes) coincides with medical advice or health advice. Compliance often has 
connotations that the health care worker, knows best, with the patient passively following the advice of 
the health care worker. 
 
ADHERENCE – The degree to which a patient follows a treatment regimen which has been designed 
in a consultative partnership between the client and the health care worker. It encourages discussion 
about treatment regimen (Adherence Network Group, 2006:18). 
 
2.6 DRUG RESISTANCE 
 
HIV is a retrovirus and therefore, mutates (changes its genetic structure) at an extraordinary rate on a 
daily basis. The result is that some strains of HIV develop that are naturally resistant to the presence of 
one or more drugs.HIV drug resistance refers to a reduction in the ability of a drug to block replication 
of HIV. 
 
Resistance can apply to a particular drug or to a class of drugs or to a combination of a drug, example, 
patients who develop resistance from taking one non – nucleosides reverse transcriptase 
inhibitors(NNRTI) are likely to be cross resistant to other drugs in the same class. The development of 
resistance thus significantly reduces treatment options (Adherence Network Group, 2006:28). 
 
2.7 CORRELATION BETWEEN ADHERENCE AND VIROLOGIC RESPONSE TO ART 
 
Adherence to ART Viral load  < 400  copies/mm3(desired effect) 
 
>95%   adherence 
 
78% 
90 to 95%  adherence 
 
45% 
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80 to 90%  adherence 
 
33% 
70 to 80%  adherence 
 
29% 
<70%  adherence 
 
18% 
(number of doses dispensed minus tablets returned) over (number prescribed) 
Example (30-5)/28=25/28=0.9 (90%) 
 
(S.A. Dept of Health, 2004:55) 
 
2.8 DEFINING ART FAILURE 
 
In resource – limited settings where viral loads are unavailable, the WHO has devised criteria for 
defining ART failure on the bases of CD4 count responses or clinical disease progression. There is 
currently no good evidence supporting these criteria. There is considerable concern that switching 
ART  regimens using these criteria will result in both switching very late (with progressive 
accumulation of resistant mutations) and switching inappropriately (as the CD4 count response is not 
infrequently poor despite optimal virological suppression). 
 
South African HIV clinicians recommend defining failure of ART on the bases of the viral load, 
irrespective of the CD4 response or the development of new HIV – related clinical features. If the viral 
load is undetectable, the virus cannot mutate and develop resistance. 
 
CD4 RESPONSE 
 
Typically the CD4+ count increases rapidly in the first month. In the first year the count typically 
increases by 100 – 150 cells and about 80cells per annum thereafter until the normal range is reached, 
provided the viral load is suppressed. However,CD4 responses are highly variable and about 10 -20% 
of patients may fail to respond despite virological suppression.CD4 count often continue to rise in the 
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presence of incomplete viral suppression(which will result in the emergence of drug resistance) until 
the viral load is high(approximately 10 000 copies/ml). 
(S. A. HIV, 2008:21 -22) 
 
2.9 ADHERENCE AND HOSPITALIZATION 
 
A study was done in Pittsburgh, United States of America, which revealed that patients with adherence 
of 95% or more had fewer hospitalization days than those with lower treatment adherence rates .Also 
concluded that there is no opportunistic infections or deaths occurred in patients who had an adherence 
of 92% or more (Peterson et al, 20: 29). 
 
This study will analyze also the reasons for admissions. (Diagnose) to exclude poor adherence 
before admissions as a reason for a diagnose. 
 
2. 10 SUMMARY 
 
Adherence to ARV treatment is essential to maintain long term benefits and avoid development of 
drug resistance. Continuous assessment of patient’s adherence to their treatment is critical. It is 
therefore important to provide all patients with a comprehensive plan to support adherence. The next 
chapter deals with research methodology. 
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CHAPTER 3: RESEARCH METHODOLOGY 
 
3.1. INTRODUCTION 
 
The research methodology has identified the method to collect data and instruments   used and the 
process that was used to analyze the data to draw up the conclusions. 
 
3.2. RESEARCH DESIGN 
 
A research design is a plan according to which we obtain research partipants and collect information 
from them. We describe what we are going to with the participants, with the view to reaching 
conclusions about the research (Welman, Kruger and Mitchel, 2005:52). 
 
Research design will specify how you will collect data that will enable you to test your hypothesis and 
arrive at some answer to the research question. It is advisable that meanwhile designing the research 
study one pays attention to ethical issues involved in the research (Christensen, 2007: 127). 
 
The research design will apply the quantitative, descriptive and qualitative studies in a real setting at 
Dr. George Mukhari hospital, participants being admitted patients qualifying to the inclusive criteria 
set. My study design was explanatory and descriptive (Hardon et al, 2001: 178 – 179). Qualitative and 
quantitative data as collected prospectively. Descriptive statistics, information gathered from the 
patients, was used for describing the data; the information was sorted, arranged and presented in a 
scientific manner (Uys & Basson, 1991: 109). 
 
3.2.1. QUANTITATIVE STUDIES 
 
Quantitative study was used. It is relevant to this study, according to (Christen, 2004:40) it is a 
descriptive type of research because it provides an accurate description or picture of a particular 
situation. Patients that were admitted at Dr George Mukhari hospital medial wards and level one wards 
were interviewed and their missed pills checked. This is a natural setting. Qualitative research Is an 
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approach rather than a design or a set of techniques. According to Van Manes (1977), it is an 
“umbrella “phrase. 
“Covering an array of interpretive technique which seeks to describe, decode, translate and otherwise 
come to terms with the meaning of naturally occurring phenomena in the social world”. Therefore, the 
qualitative approach is also fundamentally a descriptive form of research (Larry & Christensen, 2007: 
188). 
 
Qualitative approach is an interpretive multimethod approach that investigates people in their natural 
environment (Denzin & Lincoln, 1994). They are three primary components to understand when using 
the qualitative approach. 
First component – Qualitative research consists of words, pictures, documents or non-numerical 
information. Quality research is interpretative, once the data is collected; some meaning has to be 
extracted from it. 
 
Second component – Quality research is multimethod. This can include data collection method as an 
introspective analysis, interview individuals, observations of individuals, written documents. The use 
of several methods provides a better understanding of the phenomenon being investigated.  
 
Third component – Quality research is conducted in the field or in the person’s natural surroundings, 
such as school, board meeting or therapy setting (Larry & Christensen, 2007: 59 -61). 
 
3.2.2. DESCRIPTIVE STUDIES 
 
Descriptive design aims to describe and elucidate a phenomenon including factors, which may be 
related to the phenomenon.(Pilot, Becker and Hungler, 2001:19). 
Descriptive studies also use in- depth methods such as interviews to understand the phenomenon. In 
this study, interviewees were conducted, nurse and patients to understand the real gap in failing to 
support the patients with adherence to their HAART. Clinical file audits were conducted to identify 
whether doctors take full history of the patients previous treatment and re- prescribe it. 
 
3.2.3. QUANTITATIVE STUDIES 
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Quantitative research is a systematic, interactive, subjective approach used to describe and give 
meaning to life experiences (Burns and Grove, 2005:747). My research study is a real life setting 
experience. It deals with patients that are admitted in the hospital. Attitudes of health workers towards 
HIV positive patients have been picked up.Interviewes were conducted systematically and there was 
interaction between the interviewer and the responded. 
 
3.3. RESEARCH SETTING 
 
Patients were recruited from Dr. George Mukhari hospital, medical wards and level wards. The 
hospital is situated in the Gauteng province, Pretoria region, catering for about 900 000 households 
and informal settlements. The catchment area involves 26 Clinics that refer their patients to receive 
HAART. 
 
3.4. STUDY POPULATION 
 
The participants were at Dr. George Mukhari public hospital. This hospital is a tertiary institution next 
to MEDUNSA, with bed occupancy of 1000 patients. At the time of the data collection, 6000 patients 
had already being started on antiretroviral treatment. Eight wards were visited; each ward had about 38 
– 40 bed occupancy and an operational manager. 
 
Uys and Basson (1991:86) defines a study population as all the members or units of some clearly 
defined group (with distinguished criteria) of people, objects or events. Such a group is also known as 
the target population, for example, patients. In this study HIV positive patients admitted in the above 
mentioned hospital, specifically medical wards and level one wards, and are on a public HIV 
Comprehensive Care Management and Treatment Care programme. 
 
The number of wards that were targeted is eight, medical and level one ward Total number of patients 
interviewed was 25 and one registered nurse from each ward was interviewed. Level one ward is 
covered by family medicine doctors with their own Head of Department and medical wards also fall 
under internal medicine with their own Head of Department. The 25 patients were amongst the eight 
wards. Twenty five files audited belonged to the 25 participants. 
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Population – It is the study object and consists of individuals, group organizations, human products 
and events. The population encompasses the total collection of all units of analysis about which the 
researcher wishes to make specific conclusions (Welman, Kruger and Mitchel, 2005: 52). 
 
3.5   SAMPLING DESIGN 
 
As a general rule, we should not use any sample with less than 15units of analysis, but preferably one 
with more than 25 units of analysis (Huysamen, 1991). If the population size is 500, then the sample 
size should be 200.If random sampling is done, it is not necessary to use a sample size larger than 500 
units of analysis, no matter what the size of the population may be (Welman, Kruger and Mitchel, 
2005 :71). 
 
According to Uys and Basson, 1991:86 defines sampling as a process where –by the sample is drawn 
from the population. The target population is not too large, thus sampling was not done. All eligible 
patients were included in the study. Population: 25patientsPercentage suggested: 100%Number of 
responded were: 25 participants 
 
According to (Struwig & Stead, 2001:1 25). It is not possible to state what an ideal sample size is, as 
you must consider the purpose and goals of the study. Qualitative researchers are more interested in 
whether the information from the sample is rich in data and thick in description than the extent to 
which the sample’s data can generalize to the population. The study involves interviews, thus in-depth 
data was collected and that will answer the research question. According to (Burns and Grove, 2005: 
358) T he number of participants in a qualitative study is adequate when saturation of data is reached. 
 
According to (Ritchie, Lewis & Elam, 2003: 83-84 qualitative samples are usually small because : 
 From the research, a rich and a large amount of information was yielded. 
 Qualitative research is highly intensive in terms of resources so it becomes manageable when 
samples are small. 
 There is no determination of statistically significant discriminatory variables. 
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This research study used interviews, closed and open-ended questions to find out why patients on 
ARV’s do not adhere to their treatment while admitted in the hospital. The study focused more on the 
qualitative approach. According to (Hardon et al., 2001:175), comparative qualitative studies can have 
as few as ten (10) informants per group, and s study with 40 respondents is considered large. 
 
3.6 DATA COLLECTION 
 
Grove (2005: 539,733) defines data collection as the precise and systematic gathering of information 
relevant to the research purpose, objectives and questions. The researcher totally involved – 
perceiving, reacting, interacting, recording and attaching meaning. In this study, data was collected by 
use of structured questions, close and open – ended questions. 
 
Data is collect after one has laid out the procedure, obtained institutional approval, tested the various 
phases of the experimental procedure with the pilot study, and eliminated the bugs. Consent is 
obtained to participate in the study from participants, written in simple, first person and layperson’s 
language (Larry & Christensen, 2007: 382). 
 
Questions were prepared by the researcher and forwarded to the MEDUNSA Principal HIV/AIDS 
Specialist for advice and input. Data was collected by the researcher only. Interviews were conducted 
in English, Setswana and Zulu, depending on the responded choice of language. Questions were the 
same. The standard format were prepared in English and interpreted in the respondent’s choice of 
language. This approach ensured that respondents understood the questions irrespective of their 
literacy levels. Consent forms were signed before the interview. 
 
3.6.1 THE INTERVIEW 
 
According to (Cilliers, 1973:88), the interview is “the personal conversation through which research 
information is obtained”, or “A conversation with a purpose………………”or “The interview is a 
technique in which the researcher poses a series of verbal questions for the respondents in a face to 
face situation”, (Fox, 1976:225). 
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The standardized interview comprises of formally structured questions that are based on theory, 
research and/ or the experience of the interview, the questions are formally structured in that the 
wording is not altered from one participant to the next. The interviewer should be neutral and not 
engage in a conversation on the topic with the participants (Fontana & Frey, 1994). 
 
This research study used standardized interview because it is appropriate for qualitative research 
study. Advantages of this approach: 
 This technique assumes that the participants will understand the questions (Berg, 1995). 
  It enables comparisons to be made between participants. 
 The standardized interview does not enable the interviewer to probe for further data or allow 
the participants to provide information not covered in the interview (Struwig & Stead, 2001: 
98). 
 
Questions were not many, thus it was easy to observe the responded’s emotions while responding to 
the questions. All interviews took place in the respective wards where the patients were hospitalized. 
 
3.6.2 CLINICAL FILE AUDIT 
 
The 25 patients files were audited to assess whether the doctors indicated information that the patient 
is HIV positive or is on antiretroviral treatment, whether further management was planned for. This 
information is very critical for continuity of patient care and adherence to treatment. Doctors are the 
ones prescribing the treatment, nurses supervises and make sure that all patients receive their treatment 
according to prescription. Treatment was checked to verify whether nurses did give treatment and sign 
for it. 
 
Nursing audit is the process of analyzing data about the nursing process or patient outcomes to 
evaluate the effectiveness of nursing interventions (Gillies, 1982: 108). 
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3.6.3 METHODS OF DATA COLLECTION 
 
Standardized interviews with open and close – ended questions were used, for patients and nurses. 
Clinical file audit was done collect data about doctors and nurses to measure their support in ensuring 
adherence to HAART patients. This approach was relevant to this study because standardized 
interview does not enable the interviewer to probe for further data or allow the participant to provide 
information not covered in the interview (Struwig & Stead, 2001: 98). 
 
Baseline information was collected from 25 patients was used as descriptive study. The data was 
presented in the form of average and percentages. Descriptive studies do not involve manipulation of 
data; neither is there an attempt to establish causality (Burns and Grove, 205: 232). 
 
Descriptive studies attempt to describe something, for example, the demographic characteristics of the 
users of a given product and the degree to which product use varies with income, age, sex, etc. 
Descriptive studies are an attempt to provide a complete and accurate description of a situation 
(Struwig & Stead, 2001: 8). An overall picture of baseline data collected from the patients will be 
presented using the descriptive statistics guide. Descriptive statistics provide statistics summaries of 
data. The purpose of these statistics is to provide an overall coherent and straight forward picture of a 
large amount of data (Struwig & Stead, 2001: 158). 
 
3.6.5 HOW DID I COLLECT DATA 
 
I visited the Dr. George Mukhari hospital adult ARV clinic and talked to the doctor responsible for 
responding to consultations from the wards. This particular doctor has been seeing admitted patients 
for more than 3years after receiving consultations from the doctors. 
Consultation requests were specific: 
 Doctors requesting continuation of ARV treatment. 
 Doctors needed advice regarding patients experiencing ARV treatment side effects, for 
example, drug induced hepatitis or skin rash. 
 Consultations for defaulters. 
 Consultations for patients on HAART and their condition deteriorating. 
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 Consultations for private patients requesting to be shifted to the public sector ARV 
programme. 
 Consultations requesting adherence counseling in preparation for starting antiretroviral 
treatment.  
 Consultations for patients admitted as transfer from other public health sectors, mostly from 
Gauteng Province, North-West Province and Limpopo Province. 
 
3.7 DATA ANALYSIS 
 
Data analysis is a specialized area of research procedure and one should use experts in this field, this 
field provides some knowledge of the statistical techniques that are available and what technique may 
be best suited for one’s research project (Struwig & Stead, 2001:150). Data analysis is the systematic 
organization of research data, which is conducted by reducing data to give meaning (Burns & Stead, 
2005: 754; Polit et al 2001:  473). 
The raw data was sent to an in depended data analysis for analysis. The purpose for his move was to 
make sure that the researcher does not miss important information. The research questions, objectives 
and purpose were given to the data analyst.  
 
3.8 ETHICAL ASPECT  
 
Chambers Concise Dictionary (Schwarz, 1991) refers to ethics as a “system of morals, rules of 
behavior”. Conducting research is an ethical enterprise. The ethics of research provide researchers 
with a code of morals guidance on how to conduct research in a morally acceptable way (Struwig & 
Stead, 2001: 66). 
 
3.8.1 ETHICAL PRINCIPLES 
 
Prior to conducting a human or animal research study, the research researcher must determine if the 
study can be conducted in an ethically, acceptable manner (Larry &Christen, 2007: 127). 
The study involves human beings, it is critical that ethical principles are adhered to. 
RESPECT AND AUTONOMY  
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An autonomous person is a person who is capable of making decisions and following through on those 
decisions. A prospective research participant has the right to choose to participate in a research study. 
Denial of this choice shows a lack respect for that person. The participant’s informed consent must be 
obtained. 
 
BENEFICENCE AND NON –MALEFICENCE 
Beneficence means doing good and non- maleficence means ding no harm. When one conducts a 
research, one must minimize the probability of harm to the participant and maximizes the probability 
that the participants receive some benefit.  
TRUST – The researcher should establish and maintain a relationship of trust with the research 
participants. Confidentiality of the information collected from the research participants should be 
maintained. 
JUSTICE – This principle is one of the more difficult ones to accomplish and is unlikely to be fully 
achieved (Sales & Folkman, 2000; Christensen, 2007). 
 
3.8.2 PERMISSION TO PARTICIPATE 
 
 Permission to conduct a research study was received from the Stellenbosch University after the 
research proposal was accepted. 
 Permission to collect data was given at Dr. George Mukhari hospital medical wards and level 
one ward was granted by the hospital Clinical Director. 
  Request permission letter to conduct the research (see annexure: E) 
 Consent form was signed by all responded. Participants participated voluntarily. 
 
Informed consent – This involves informing the participants of all aspects of the research from the 
purpose and procedures to any risks and benefits including incentives for participation. Participants 
can then make an informed decision and choose to either decline to participate in the study or give his 
or her informed consent (Larry & Christensen, 2007). 
It is always important to get permission to use the data from the person who provided it. In cases 
where patient records are used, permission for use of such records should first be obtained from the 
institution of which it belongs. When research is undertaken at a health service, permission for such 
Stellenbosch University  http://scholar.sun.ac.za
39 
 
research should first be obtained from the authority in charge of the service. The patient should be 
informed about the research in such a way that he or she thoroughly understands it (Uys &Basson, 
1991: 99). 
This study deals with HIV positive patients, confidentiality and privacy should be maintained. Patients 
need to be assured that their identity is protected. 
 
3.8.3 CONFIDENTIALITY AND PRIVACY 
 
UYS & Basson (1991:98 defines confidentiality as “No information provided by a patient should be 
divulged or made available to any other person”. The anonymity of any person or institution is 
protected in the report by ensuring that it is not possible to relate that particular data to a particular 
person or institution. The patient’s privacy should be ensured. Privacy means that a person can behave 
and think as he or she pleases without interruption and without the possibility that private conduct or  
thoughts may later be misused to embarrass or humiliate the patient. To ensure privacy during the 
interview, bed screens were used to avoid disturbance and to maintain privacy. 
 
3.9 CONCLUSION 
 
The chapter focused on research methodology. Described the qualitative and descriptive studies taken 
to understand why hospitalized patients on HAART do not adhere to their treatment plans at Dr. 
George Mukhari hospital, medical wards and level one wards (total of 8 wards). Descriptive approach 
was used in the baseline data. Qualitative approach was used from the one- on -one interview data. 
Conducting a research project it is an ethical exercise. Ethical principles were adhered to. 
The next chapter will focus on data analysis and findings. 
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CHAPTER 4 
 
DATA ANALYSIS AND FINDINGS OF THE STUDY 
 
4.1 INTRODUCTION 
 
The chapter will present the findings from the data collected in the study. The results are presented 
using the grading poor/good for the support given by the doctors and nurses, pill counting according to 
adherence percentages, non – compliance classification, pie-chart, Bar-charts and tables. 
 
4.2 WARD EVALUATION RESULTS 
 
4.2.1. TABLE: DESCRIPTIVE STATISTICS [RESPONSE FROM 25 PATIENTS 
INTERVIEWED} 
ANTIRETROVIRAL DRUG ADHERENCE – What happens when patients are hospitalized to 
medical wards and level one wards in Dr. George Mukhari hospital, and they are on Highly 
Active Antiretroviral Therapy [HAART] 
DATA COLLECTED FROM 26/01/09 – 02/03/09 
 
Code Gender Age 
In 
years 
Diagnose How 
long on 
ARV.s 
Regimen Reminde
r 
Where 
ARV.s 
kept 
Admitt
ed 
Treatm
ent 
time 
consiste
ncy 
Dose 
since admi
001 M 60 Pleural 
effusion 
 
2month
s 
1(a) watch locker 21/1/09 No Stav.10 
Stoctrin 5
002 F 32 
 
Tumor 
spine 
3month
s 
1(a) cell locker 20/01/0
9 
No 3doses 
003 M 52 PCP 
pneumonia 
2month
s 
1(a) TV & 
asking 
locker  O8:00-
09:00 
nil 
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other 
patients 
004 F 47 
 
Cardiac(M
VD) 
2yrs 1(a) cell locker 13/01/0
9 
Yes nil 
005 F 50 Hypertensio
n 
3month
s 
1(a) nurses locker 07/01/0
9 
No Lam. 4 
Stav. 4 
Stoc. 2 
 
 
006 F 36 Gastro 
Enteritis 
>1year 2 cell fridge 24/1/09 Not 
given 
from 
the 
fridge 
 
 
3kaletra 
007 F 29 Lymphoma 
R.  
Inguinal 
lymph node 
 
4month
s 
1(a) nurses locker 10/01/0
9 
No Stoc. >5 
008 F 55 Tuberculosi
s 
3month
s 
 
1(a) nurses nurses 17/01/0
9 
Yes nil 
009 M 32 Cryptococc
al 
Meningitis 
 
2month
s 
1(a) nurses locker 17/010
9 
No >3 
010 F 32 Meningitis 6month
s 
 
2 cell nurses 13/01/0
9 
No Not sure 
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011 F 30 Chest 
infection 
7years 
Started  
from 
private 
 
2 nurses locker 12/01/0
9 
Yes nil 
012 F 36 Gastro 
Enteritis 
>1year 1(a) watch locker 12/01/0
9 
No Stav. 6 
Lam. 6 
Stoc. 3 
013 F 33 Pneumonia 
 
1month 1(a) Guessing 
time 
 
locker 29/01/0
9 
No 3days 
014 F 
 
35 Respiratory 
Distress and  
Karposis 
spots oral 
thrush 
3month
s 
1(a) Guessing 
time 
locker 29/010
9 
No Did not cou
015 M 39 ? TB 
Meningitis 
 
 
1year 
4month
s 
1(c) cell bag 11/2/09 No >3 
016 M 37 Chronic 
Renal 
Failure 
 
1year 1(c ) cell locker 10/02/0
9 
Yes nil 
017 M 61 Liver 
Disease 
1month 1(a) and 
TB 
treatment 
for 
2months 
nurse locker 9/02/09 No >3 
018 F 28 Anaemia 
 
4month
s 
1(c )AZT NONE locker 3/2/09 guessin
g 
Not sure 
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019 F 31 Chronic 
Recurrent 
Anaemia 
 
1year 1( c)AZT NONE locker 11/02/0
9 
guessin
g 
nil 
020 M 51 Severe 
Pallor 
6month
s 
1(c )AZT Nurses locker 09/02/0
9 
No <3 not 
because tre
was stoppe
021 F 26 Drug 
Induces 
Hepatitis 
2month
s 
1(a) and 
TB 
treatment
Nurses locker 18/02/0
9 
No Not sure 
022 M 40 Pencytopae
nia 
1year 
2month
s 
 
1(c )AZT Nurses locker 19/02/0
9 
No forgotten 
023 F 42 AZT 
induced 
anaemia 
1year 2 cell fridge 25/02/0
9 
No Not yet su
are taken
ARV.s 
024 F 30 Drug 
induced 
hepatitis 
1month 
and 
2month
s on TB 
treatme
nt 
1(b) 
Post 
delivery 
watch locker 24/02/0
9 
T/F in 
from 
Jubilee 
hosp. 
Too 
sick to 
remem
ber 
anythin
g, but 
days. 
Given 
treatment
025 M 62 Anemia and 
Gynaemast
macia 
1year 
7month
s 
1(c )AZT Cell off-
asking 
other 
patients 
for time 
Locker- 
treatme
nt 
mixed  
25/02/0
9 
No Treatment 
changed 
morning 
Kaletra 
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4.2.1.1 RESEARCH FINDINGS FROM THE WARDS  
 
 Patients focused on their TB treatment more than ARV, s because nurses were giving them 
from the medicine trolley. 
 Patients focused on new treatment given on admission. 
 Nurses were not aware that other patients were on ARV’s. One patient called me and asked if I 
don’t want to check her because she was also on antiretroviral treatment. 
 Treatment in the fridge easily forgotten by nurses. 
 One nurse remembered to give the patient treatment when she saw me. The patient was 
suppose to receive treatment at 08:00 and it was 12:00. 
 Some patients cited fear of side effect. 
 Some patients cited loss of hope when treatment was changed or stopped temporally. 
 Patients less than 3moths on ARV’s did not feel free to take their ARV’s openly. One patient 
cited the reasons for not sticking to the same treatment time as privacy being minimal in the 
wards. 
 0nly one patient was reluctant to be interviewed, she had started ARV’s from private in 
2002.When I left she called me back and told me that she is scared to be interviewed because 
the public sector it’s not long that it started to give ARV’s. She was currently unemployed that 
is why she was referred to a public sector. After reassuring her of the confidentiality and 
reading the questions to her, she opened up. 
 
4.3 FINDINGS FROM THE DESCRIPTIVE TABLE (ANSWERS FROM THE PATIENTS) 
 
4.3 .1 MEASURING LEVEL OF ADHERENCE:  
 Pill counting: From 25 patients interviewed: 
 
>95% adherence level was identified from……………7patients (28%) 
<95% adherence level was identified from…………….18patients (72%) 
Limitation of self-reporting – This measurement of adherence relied on patients and it is easy for them 
not to tell the truth. Pill counting by the researcher was done to check if the patient was taking the right 
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antiretroviral treatment as he/she mentioned them and to check whether right pills are in the correct 
containers. Only one patient had her pills mixed in one container. 
 
4.3.1.2 Five (5) patients reported 100% adherence since admission.  
 
This is their length of time on antiretroviral treatment and type of treatment Regimen they are in. 
 
Patient 
 
Regimen Length of time on ARV’s 
003 
 
1(a) 2months 
004 
 
1(a) 2years 
008 
 
1(a) 3months 
011 
 
2 7years 
016 
 
1( c)AZT 1year 
 
 
4.3.1.3 Patients on Regimen 2(only 4 out of 25patients) 
 
Patients Period Adherence Remarks 
 
006 >1year <95% Nurses were giving treatment and 
they did not bring Kaletra from 
the fridge. The patient thought 
other nurses did not know 
ARV’’s. 
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010 6months <95% Reported that she was too sick 
and thought she was on new 
treatment that focused on 
Meningitis. 
 
011 7years 100% The patient is highly motivated 
about her ARV treatment. 
 
023 1year <95% Reported that she is on new ARV 
regimen but before the change 
she did skip some doses, she was 
too sick and too weak. 
 
4.3.1.4 Reminders (To remind patients to take treatment on time) 
 
Reminder 
 
Number of patients % 
Cell 
 
8 32% 
Watch 
 
3 12% 
Nurses 
 
9 36% 
Television 1 4% (When I was in the ward, the 
television was off) 
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Guessing time 2 8% 
 
None(not taking same time 
and pills were in the locker 
One patient said she has 
never skipped pills but had 
nothing to check time) 
 
2 8% 
 
 
4.3.1.5 Where pills were kept 
 
Patient’s side locker 
 
20 patients 80% 
Kept by nurses 
 
5 patients 20% 
 
 
4.4 EPLORATION OF FACTORS ASSOCIATED WITH NON-ADHERENCE  
 
NON-ADHERENCE PREDICTORS INCLUDED THE FOLLOWING: 
 
 Side effects of antiretroviral treatment. 
 Stigma that is related to HIV and AIDS. 
 Non-disclosure of ARV’s to nurses or doctors 
 Lack of support from the nurses 
 Loss of hope from the patients when ARV Regimen where changed. 
 Patient’s condition while hospitalized. 
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This extends to patient sleeping, experiencing pain or patient depressed and feeling weak to take 
treatment on his own or even to shout for nurses to give assistants. 
 
 Hospital counselors do not visit admitted patients for continuous counseling. 
 
 Patient’s not understanding the importance of continuing with ARV’s and the new treatment 
(for the current diagnose) given by nurses. 
Patients were exhibiting a sense of pill burden. 
 
 Lack of privacy in the wards 
 
 Patients becoming depended, relying too much on nurses. 
 
4.5 PATIENT’s KNOWLEDGE ABOUT ANTIRETROVIRAL TREATMENT 
 
Question: 
When asked about the treatment skipped while being hospitalized. The researcher expected the 
patients to know their treatment and did not guide them. 
 
Answers from the patients: 
 
 Three patients described the three different containers and how many pills missed from each 
container. 
 Pronunciation of pills names was a struggle but the researcher new the drug names. 
 Other patients were describing the shapes and the colors of the pills. 
 Three patients were so impressive, they described their pills and the names very well. 
 The level of education was not requested from the respondents; definitely it had an influence 
but is not going to be discussed in detail. 
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 The 4 patients on Regimen 2 antiretroviral treatment were aware that their treatment was 
different and that Kaletra was kept in the fridge. No one of the patients kept their treatment in 
their bed side locker. 
 
 
4.6 MEASURING THE LEVEL OF SUPPORT GIVEN BY HEALTH CARE WORKERS TO 
PATIENTS RECEIVING HAART WHILE HOSPITALIZED 
 
4.6.1 RESEARCH FINDINGS FROM THE DOCTORS CLINICAL NOTES  
 
FINDINGS FROM PATIENT’S AUDITED FILES [25 files] 
 
 Sixteen [16] files clinical notes reflected doctors writing that the patients are RVD positive and 
patients are on ARV treatment. 
 
 Sixteen [16] files ARV prescribed. 
 
 From other files doctors mentioned that the patient had treatment from home but did not review the 
ARV treatment. 
 
 Doctors that reflected that the patients were on ARV treatment mentioned in their plan to send a 
consultation to an ARV clinic 
 
 
ACTIVITY BY DOCTOR 
 
PERCENTAGE 
Antiretroviral’s  prescribed 
 
64% (16 files) 
Antiretroviral’s  not prescribed 
 
36%(9 files) 
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RESEARCH FINDINGS FROM THE NURSES CLINICAL NOTES AND QUESTIONNARES 
 
RESPONSE FROM REGISTERED NURSES: 
1. When asked how do they identify a patient on ARV’s. 
 When completing a nursing care plan a nurse should ask whether on any treatment. 
 These patients do not disclose their treatment because they were told it is confidential. 
 Other patients do tell us that they have treatment with them. 
 
 
2. They were asked where they keep Individual’s ARV treatment. 
 Kept in the medicine trolley and in the fridge [4 registered nurses]. 
 Patients prefer to keep them in their lockers or bags. 
 If the treatment is not prescribed, we tell patients to keep it and drink the way they were taught. 
 We are not sure of ARV side effects; we keep them next to the patients. 
 
3. They were asked if they stick to individual’s treatment plan. 
 Patients have different times and we have staff shortage. 
 We give them according to routine medicine giving times, starting between 08:00 – 09:00[ 8 
registered nurses] 
 
4. Interviewed nurses were asked if they were trained with HIV/AIDS management 
 Two [2] registered nurses were trained and well conversant about ARV patient management. 
 Registered nurses cited shortage of staff and rotation of staff that is trained moving to other 
wards. 
 Nursing managers are not choosing appropriate people to go for training. 
 
5. Medicine given and recorded in the nurse’s medicine sheet [25 files audited] 
 
ARV treatment recorded as given 
 
9 files[36%] 
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ARV treatment not recorded 
 
16files[64%] 
 
4.6.3 Hospital policy re-admitted patients bringing their own medication 
 
According to Dr. George Mukhari hospital policy, on admission all treatment brought in by the patient 
from home, is disclosed to the doctor for review. If the doctor thinks it is still relevant to the 
diagnoses, then it will be reviewed. All treatment irrespective of antiretroviral must be recorded that 
the patient has taken. Research findings revealed that nurses did not take accountability by ensuring 
continuity of patient’s treatment. Other nurses were aware that the patients were on ARV treatment, 
but expected the patients to take responsibility of taking their treatment on time and still remind nurses 
even if the treatment is kept by them. The condition of the patient [acuity level] and the level of 
understanding, emotional and psychological status were ignored. Files that were recorded, treatment 
time was not according to the patient’s treatment plan, other medicine recording sheets had gaps that 
indicated inconsistency. 
 
4.6.4 Standard operating procedure[SOP] 
 
Standard operating procedures were not available in the wards to guide the nurses on how to manage 
patients on HAART. This was evident because there were different reasons for not adhering to 
patient’s treatment times.  Other nurses cited shortage staff. 
 
4.6.5 Quality care 
 
Quality care can be described as care that exceeds set standards and norms. It includes care that is 
professional, exceptional and of a very high standard in the eyes of both the person caring and the one 
being giving the care. Compliance with standard s set by various councils and professional bodies is an 
example of quality care. Such care should improve health and meet the health care needs of patients 
and clients (Khokho, 2009). 
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The care given by nurses to patients receiving antiretroviral treatment in the wards I visited, did not 
meet the standard of being called “Quality “. Unit standards were not there, example, handling of ARV 
drugs. According to South African HIV/AIDS Management Care and Treatment protocol, ARV drugs 
should be controlled as schedule 5 drugs. They should be kept under lock and key not in patient’s 
lockers. 
 
4.6.6 Attitudes of nurses 
 
It was difficult to conclude whether the eight registered nurses represented the entire nurses in the 
medical wards and level one wards. The results revealed that patients on HAART were treated 
differently and it was not necessary except for the privacy and the confidentiality that is  required 
solely to protect the individual The health sector has been identified as one of the areas in which 
discrimination occurs (Mahindra, et al; 2007). Studies have documented negative attitude to People 
Living with HIV/AIDS in health care settings in Nigeria and elsewhere (Adelekan et al., 1995; Fido & 
Kamezi, 2002; Hengten, Jaureguiberry, Ramiliarisog, Andrianantoandro & Belec, 2002; Quach, 
Mayer, McGarvey, Lurie & Do, 2005; Reis et al; 2005). Physicians and nurses have been reported to 
be uncomfortable when administering medical procedures to HIV infected patients (Oyeyemi, & 
Bello, 2006, 2008). 
 
4.7 MY EXPERIENCE WHILE COLLECTING DATA 
 
While collecting information from the patients, I realized that it was not only a matter of getting 
consent and collecting data. I had to do drug counseling as well, because for the patients to adhere to 
their treatment, they definitely needed a person to remind them about their responsibility and not to 
forget that their treatment should not be skipped because their quality of life is going to be 
compromised. Minimum time spent with one patient was 20minutes. Adherence encourages discussion 
about treatment. 
 
Collecting data from nurses and doctors gave a chance to cover even the training need analysis 
regarding HIV and AIDS, also Tuberculosis management. It was interesting to discover that much as 
patients do not disclose to each other, they are actually able to identify other patients taking treatment 
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from their lockers. When I was in one ward, having completed my talk with another patient, another 
patient called me to tell me that she is also on HAART. The sister who showed me patients was not 
aware that the patient was also on HAART. 
 
4.8 CONCLUSION 
 
The chapter presented the research findings. The findings were deducted from the interviews done 
from 25 patients on HAART during hospitalization, information from 8nurses in supporting patients to 
adhere to their treatment and contributions of the doctors in proper history taking leading to 
prescribing all treatment necessary for the patient’s recovery and maintenance of long-life treatment.  
The next chapter will cover the discussions, conclusions and recommendations from the researcher. 
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CHAPTER 5 
 
DISCUSSION, LIMITATIONS, RECOMMENDATIONS AND CONCLUSION 
 
5.1 INTRODUCTION 
 
This chapter will present a discussion of the research findings with the reference to the existing 
literature reviewed in relation to antiretroviral drug adherence to hospitalized patients. Conclusions 
will be drawn from there and recommendations made. According to Struwig & Stead (2001:228 and 
232) discussion describe the data and compare the interpretations of the data with the existing theories 
and literature on the topic. Discussion, summary and recommendations refer to whether there is a 
proper discussion and summary of the research and whether useful recommendation was presented. It 
should include the discussion that is linked to the literature, aims and results. 
The purpose of my research study is to investigate ARV drug adherence of patients on South Africa’s 
government ARV government while being hospitalized at Dr George Mukhari hospital, in medical 
wards and level one ward. 
 
The specific objectives of this research study are: 
 
 To measure the levels of adherence amongst hospitalized patients on HAART. 
 To explore factors associated with non-adherence. 
 To measure the level of support given y health care workers to patients on HAART while 
admitted. 
 
5.2 GENERAL OBSERVATION FROM THE EIGHT WARDS 
 
The welcoming from the nurses was very positive and willing to help without complaints in 
responding to the questionnaires. All registered nurses showed me the patients that were on 
antiretroviral treatment without consulting others or referring to the nominal book. This was the 
impression that they knew their patients. I brought along a list of patients from their hospital adult 
ARV clinic consultations requested. They really appreciated that because they were not aware of other 
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patients that were on HAART. This indicated to me that those patients disclosed to the doctors and not 
to the registered nurses, meaning that their treatment was in their bedside lockers. This was one factor 
that contributed to treatment interruption because if the patient becomes too sick, he/she would not be 
able to remember to take treatment as expected. 
 
5.3 PILL COUNTING 
 
Pill counting was done from 25patients and only missed pills were counted after asking the individual 
patients. It was difficult to count from their respective pill containers because patients would not 
remember the date treatment issued and the pills that were remaining in the used pill containers. The 
approach was to count the number of pills missed since admission. According to the South Africa’s 
HIV/AIDS Comprehensive ,Care ,Treatment and Management  guideline,2004: ideally for a patient to 
be termed as adhering to ART, he/she must take more than 95% of their doses(that is, missing less 
than 3doses in a month). 
If a patient is taking less than 95% of their doses, they are at risk for developing viral resistance and 
ultimately virological failure. Research findings revealed that 28% of patients their adherence level 
will be >95% and 72% their adherence level will be <95% and 62% might have missed more than 3 
doses of their treatment since admission. This method was not easy because not all patients seemed to 
be sure of accurate number of pills missed. The focus was on identifying whether patients interrupt 
their treatment thus not adhering to the prescription and not suppressing the HIV virus in their blood 
system. 
According to Treatment Helpline Direct in South Africa: 
 Patients that would take treatment according to doctor’s prescription are 5%. 
 Patients that would not take all treatment according to doctor’s prescription are 95%. 
This literature concurred with my research findings because 28% of patients adhered to their treatment 
and 72% of patients did not adhere to their treatment. It was interesting to note that other patients 
omitted Efaviernz pills purposely to avoid side effects, thus altering the doctor’s prescriptions. 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
56 
 
5.4 PATIENTS THAT REPORTED 100% ADHERENCE WHILE HOSPITALIZED 
 
Patients that reported to have taken 100% of their ARV’s while admitted were 5(20%). One patient 
was on Regimen 2, 3 patients on Regimen 1(a) and 1 patient on Regimen 1( c).  From the five patients, 
three patients were less than 4months on HAART and two patients were more than 1year on HAART. 
It was difficult to conclude whether the period on antiretroviral treatment has anything to do with 
adherence to treatment, not ignoring acquity level of the condition of the patient while admitted. There 
is evidence that there are fewer adherences as times progress. What is required is continuous 
monitoring and support of all patients on lifetime antiretroviral treatment. 
 
5.5 ADHERENCE OF PATIENTS ON REGIMEN 2 ANTIRETROVIRAL TREATMENT 
 
ART regimen taken by participants during the study 
Treatment Regimen 
 
Number Percentage ( % ) 
Reg.1(a) 
D4t/3TC/Efavirenz 
 
13 52% 
Reg.1(c ) 
AZT/3TC/Efavirenz 
 
7 28% 
Reg. 1(b) 
D4t/3TC/Nevarapine 
 
1 4% 
Reg.2 
AZT/ddl/Lopinavir& 
Ritonavir 
 
4 16% 
TOTAL 
 
25  
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In the research findings 4 patients (16%) are on regimen 2 treatment. Only one patient the adherence 
was >95%. One would expect regimen 2 patients to be assertive and strict about their treatment 
because South Africa has only 1 and 2 regimens to give to the public presently. Once patients are 
admitted, mostly rely on nurses to continue with the new treatment hoping that what-ever treatment 
given will cover even the previous illnesses. 
 
 
 
5.6 THE ROLE OF TREATMENT REMINDERS IN MAINTAINING ADHERENCE LEVEL 
AT >95% 
Treatment Reminder 
 
Number Percentage % 
Cellular phone 
 
8 32% 
Television 
 
1 4% 
Watch 
 
3 12% 
Nurses 
 
9 36% 
Guessing time 
 
2 8% 
Not using reminders 
 
2 8% 
 
Much as all the patients were given information about the importance of having reminders so as to 
take their treatment on time, they still need to be educated to choose the reliable methods according to 
the situations they find themselves in. Only 36% of patients relied on nurses, this number is too low, 
nurses need to do more, take over by  giving treatment to sick patients, supervise and support them 
while being  hospitalized. Literature indicated that when the patient is depressed and too sick, that 
would have a negative impact on adherence. 
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The use of cellular phones is preferred by patients and it is encouraged even to those using other 
methods. The sound of the alarm is alerting a patient even if sleeping. Other patients using other 
methods reported to be waiting for relatives to bring them chargers because their cellular phones were 
battery low. 
 
The use of a television, watch and guessing time was found to be totally unreliable to remind a 
hospitalized patient. The patients that were using watch their watches did not have the alarm systems. 
During the interview, for the patient who said she was using a television, it was switched off, 
indicating that the patient has no control over it. Even if it was switched on, individual patients have 
no control over channels to easily estimate time according to a certain programme. The two patients 
(8%) which reported not to be using treatment reminders are a sign of not taking treatment according 
to treatment plan, not every day same time. That is why all admitted patients should be monitored and 
nurses take accountability for patients’ treatment. 
  
5.7 STORAGE OF PILLS IN RELATION TO CONTINUITY OF TREATMENT AND 
DISCLOSURE 
 
Patient treatment should be kept by nurses in the medicine trolley or medicine cabinet. The reason 
given by nurses for not taking control of patient’s antiretroviral treatment is that patients prefer to keep 
them. Only 20% of patients kept their treatment with nurses. The other reason given by the registered 
nurse for not keeping patient’s treatment is that, if the doctor did not prescribe or review the treatment, 
they tell the patient to keep the pill. Another reason given by a registered nurse is that, they are not 
conversant to ARV drug side effects as a result they prefer pills to be kept next to the patients. 
 
This is totally not accepted. According to the hospital policy all treatment should be kept safe, under 
control measures by nurses. Patients need to be protected from any harm or medico- legal hazards that 
are preventable. Nurses are suppose to communicate with doctors to review treatment. It is the 
responsibility of the nurses to require knowledge of all the treatment given to patients and to read the 
inside leaflets from treatment containers. How-ever, I did acknowledge that there is a great need for 
HIV and TB collaboration training for nurses and doctors. 
 
Stellenbosch University  http://scholar.sun.ac.za
59 
 
 
         
         
         
         
           
 
Where pills where kept by 25 patients 
 
 
  
  
  
  
  
  
  
It is critical that nurses take control of giving patients treatment while hospitalized, to ensure 
continuity of treatment and to reflect reliable evidence that the patient has taken his/her doses. To 
achieve these benefits, a high level of medication adherence is necessary. If patients interrupt their 
treatment, they might end up requiring Regimen 2 pills, which are costly and not easy to take due to 
specific conditions that need to be adhered to. 
 
The research findings supports Steel G.et al; 2005:11, that cited that, if adherence falters, resistance to 
antiretroviral may develop, thus rendering the treatment regimen ineffective  and possibly require a 
more costly and toxic regimen change. 
 
5.8 PATIENTS KNOWLEDGE ABOUT ANTIRETROVIRAL TREATMENT 
 
Generally all patients knew how to distinguish their ARV drugs from other pills. Since South Africa 
HIV/AIDS management is using a triple therapy, patients easily identified that they take their 
treatment from three different containers but pronunciation of ARV drug names was difficult. The 
researcher was conversant to ARV drug names; it was easy to finish up the name of the drug. If the 
doctors and nurses had asked them all about the treatment they were taking before admission, they 
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would have picked it up and continued the treatment. Patients that were on Regimen 2, their treatment 
was kept in the fridge but still patients were missing their doses. One patient commented to me that 
she suspects the nurse does not know Kaletra pills that is why she did not come back to give her 
treatment. 
 
5.9 MEASURING THE LEVEL OF SUPPORT GIVEN BY DOCTORS IN SUSTAINING 
ANTIRETROVIRAL DRUG ADHERENCE 
 
Research findings revealed that from (16) 64% of files antiretroviral treatment was prescribed for 
patients and from (9) 36% of files antiretroviral treatment was not prescribed. 
 
 
 
 
 
 
        
          
          
          
          
          
          
          
          
          
          
          
          
          
          
 
Antiretroviral treatment prescribed by doctors 
for hospitalized patients     
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The reason that can be made from the doctors that did not prescribe or review treatment for patients 
that are already on antiretroviral treatment when admitted is negligence. If proper history is taken, the 
previous notes read and correlated to the diagnose, surely there will be continuity of patient 
assessment and management plan. According to South Africa national Antiretroviral Treatment 
Guideline (section3) of 2004, medication adherence is an essential element to maintain the health 
benefits of ART.  
 
Clinicians are required to monitor and evaluate adherence and respond appropriately. The South 
Africa ARV treatment guideline emphasizes that there is a need for training as a means to ensure 
patient adherence to ART. The level of support from the doctors to sustain adherence to treatment was 
poor. It needs to be 100% not 64% as discovered, it cannot be compromised, and it can only be good 
(100%) or poor (< 100%). Quality patient care also means not keeping the patient’s stay long in 
hospital by not prescribing and monitoring that the treatment is received. 
 
5.10 LEVEL OF SUPPORT GIVEN BY NURSES TO HOSPITALIZED PATIENTS IN 
SUSTAINING ANTIRETROVIRAL DRUG ADHERENCE 
 
My research question needed an answer to know how far nurses are supporting patients under their 
care, to continue their lifetime treatment (HAART). The support from nurses was also poor. The 
registered nurses did not take a lead and develop unit standards for personnel on how to manage HIV 
positive patients on HAART. Nurses still need information on shared confidentiality and their 
accountability that patients should be treated the same and should be given treatment as expected. 
 
Nurses are supposed to be advocates for patients. If doctors have not prescribed the treatment, they 
should communicate amongst themselves for continuity of treatment. Both nurses and doctors are 
equally responsible and accountable for quality patient care which cannot be graded to under TOTAL 
QUALITY PATIENT CARE. Dealing with human beings one cannot do one part and compromise the 
human life because it can be too late to reverse the negligence and loose the patient. 
 
Other patients exhibited a sense of not trusting health care providers about disclosing their HIV status 
and ARV treatment. Response from other patients was confusion about their treatment plan time 
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changing because nurses were sticking to their routine schedule. The research findings indicated a 
need for strengthening the nurse-patient relationship so that patients become free to communicate with 
staff about their concern and fears. Patients needed to be re-assured that on discharged they need to 
continue with their individual treatment plans that suite their life programmes. 
 
5.11 PATIENT’s RIGHTS CHARTER 
 
According to South Africa Patient’s Right Charter, (S. A. Department of Health, 2000). 
Every patient has a right to: 
 Provision for special needs (in the case persons with HIV or AIDS patients). 
 Confidentiality and privacy 
 Continuity of care 
 Complain about health services (everyone has the right to complain about health care. 
 
According to South Africa Department of Health, Patient’s right charter should be displayed in all 
health institutions and patients educated about their rights and their responsibilities when visiting 
health sectors. The community has also taken –up the responsibility of advocating for their families. It 
is critical for the health care workers not to take patients for granted, that they will not report 
dissatisfaction, about the service they have received. 
 
Patients with HIV and AIDS have special needs; health care workers should respect them and comply 
to reduce unnecessary law suits. If a patient insists that he/she will keep the treatment, the nurse should 
still take accountability to see that the patient takes treatment as prescribed. The information should be 
recorded so that as soon as the patient becomes too sick to take treatment on his own, nurses will take 
over. 
 
The patient should still be supervised and other patients protected. Nurses still need to be empowered 
with information so that the importance of disclosure, shared confidentiality amongst health cares 
workers to maintain continuity of care. 
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5.12 FACTORS THAT CONTRIBUTED TO NON-ADHERENCE OF HOSPITALIZED 
PATIENTS ON HAART 
 
5.12.1 STIGMA 
 
Other patients cited lack of privacy in the wards which indicated that they needed to hide themselves 
when taking their antiretroviral treatment. They did not want other patients to know about their HIV 
status. Surely this factor had a negative impact on their adherence to the antiretroviral treatment. 
 
5.12.2 ANTIRETROVIRAL DRUG SIDE EFFECTS 
 
Patients had a tendency to avoid the next dose of treatment to minimize the effects of side effects , not 
realizing that the drug levels in the blood system decreases. This barrier to adherence contributed to 
patients avoiding to report side effects because their treatment will be changed. 
 
Patients reported to be losing hope when ARV’s are changed. The idea of having only regimen 1 
and 2 in South Africa has an impact on patients, they become anxious or worried that, what if the last 
regimen does not work. That is why continuous education, support and adherence counseling is 
important. 
 
5.12.3 LACK OF SUPPORT FROM THE NURSES AND DOTORS 
 
According to the research findings, 64% (16) of files had not been recorded by nurses that the patient 
received or took antiretroviral treatment and 36% (9) of files had not been prescribed or reviewed 
antiretroviral treatment by doctors. It was expected that only 36% of files would have not been 
recorded by nurses because doctors did not prescribe ARV treatment from 36%. It showed that even if 
the doctors prescribed there was no evidence that the patients took their treatment. Support from both 
health care providers was poor to promote adherence and motivate patients. 
 
Health care providers are thought to play a central role in providing support for adherence to 
antiretroviral treatment. Evidence from qualitative studies of HIV positive individuals suggest that 
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adherence may be influenced not only by health care providers, but also by members of the 
individual’s social network who are aware of the individual’s HIV positive status (Roberts & Mann, 
2000). This study is relevant to my study because the community had a concern that the patient’s right 
charter was ignored patients were interrupting their treatment while admitted. Informed family 
members and treatment partners may play a role in supporting daily adherence. This involvement of 
family members or friends in promoting adherence need to be further explored because it came as a 
complain but it is a necessary factor because HAART is a life time treatment. We cannot rely on 
health care providers only; the patient’s social cycle should be explored. 
 
5.12.4 ADHERENCE LAY COUNSELLORS NOT VISITING ADMITTED PATIENT 
 
All participants on HAART had been given pre-adherence counseling by lay counselors in their 
respective health facilities. From the research findings it is evident that adherence counseling should 
be continuous and not stop when patients are hospitalized. At Dr. George Mukhari hospital lay 
counselors do visit new patients for pre-adherence counseling. The numbers of lay counselors need to 
be increased to cover even the wards for continuous adherence support for all patients admitted that 
are on HAART. While I was visiting the different wards, there were Tuberculosis (TB) community 
counselors seeing admitted patients but not patients on HAART. TB/HIV collaboration should be 
strengthened so that TB counselors can also be increased and work together with ART adherence 
counselors. It would be beneficial to the patients if lay counselors are equipped with HIV and TB 
information. 
 
5.12.5 PATIENTS EXHIBITING A SENSE OF PILL BURDEN 
 
Hospitalized patients have to take antiretroviral treatment and the new treatment for the current 
diagnose. Other patients interrupted their treatment and focused on the new treatment given by nurses. 
This did not come up as a complain but they did not see it as interrupting the treatment because they 
were going to take their treatment. 
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5.12.6 LACK OF PRIVACY VERSUS NON-DISCLOSURE 
 
Patients actually complained that, they are unable to take their treatment in the ward because there is 
no privacy. Lack of privacy and non-disclosure of treatment were impacting on each other. For the fact 
that the patients did not disclose his/her ARV treatment, they would need privacy for the health care 
workers and other patients not to know about their treatment. This is difficult to maintain, because 
nurses and doctors would always be there in the wards. There is no need for drawing up curtains for 
patients to take their oral treatment. It is only when an injection is given particularly on the gluteus 
muscles (buttocks) that a privacy is required.  
 
5.12.7 PATIENTS BECOMING DEPENDENT ON NURSES 
 
This is understood when the patient is too sick to even remind the nurses about their treatment. 
Patients need to be taught to be responsible and assertive. They should demand their treatment because 
this is life time treatment, their life rely on ARV treatment and not on individuals (Mehta et al; 1997). 
According Mehta (1997) adherence also declines when illness becomes severe. 
The patient may fall asleep due to effects of other treatment received or pain. This can be seen as the 
greatest accidental factor that can contribute to treatment interruption. 
 
5.12.8 ADHERENCE versus COMPLIANCE 
 
Compliance is the corner stone of any medical treatment. The literature states that if the patient fails to 
carry out the instructions of the doctor a return to good health is very unlikely. Compliance often has 
connotations that the health care worker knows best, with the patient passively following the advice of 
the health care worker. This was exhibited by other patients, thinking that nurses know best, even if 
when the ARV’s were not given. The new treatment given by nurses was seen as comprehensive. 
Patients decided not to be active in taking responsibly for their treatment. 
 
Adherence encourages discussion about patient’s treatment plan. This becomes difficult for other 
patients because nurses give treatment according to their unit routine times. In fact nurses should be 
educated that patients need an open discussion about changing times of treatment. This is important 
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because on discharge the patient should adjust to his/her own treatment plan (Adherence Network 
Group, 2006:18). 
 
The patients need continuous counseling to ensure that all the elements mentioned during the pre-ARV 
adherence counseling are still maintained and practiced. 
 
Patient ART requirement list: 
 Education - The need for the patient to be educated. 
 Intelligence - The approach should consider the level of understanding of the patient, example, 
using the patient’s home language. 
 Responsibility – The need for responsibility, accountability, commitment and self discipline. 
The patient should understand that if they break any of these criteria, there is a likely hood of 
treatment failure. 
 Compliant – Patients need to take treatment as instructed by their doctors. In the case of ARV 
treatment, to take treatment also as instructed the pharmacist after drug counseling. 
 
Categories of Non – Compliance (classification) 
Category 1 non-compliance 
 Failure to take drugs at dosages prescribed. 
 Failure to take drugs at the times stipulated. 
 Failure to take drugs in the manner stipulated, example, on an empty stomach. 
 
Category 2 non – compliance 
 Failure to adhere to a healthy lifestyle. 
 Failure to adhere to a risk free sexual behavior. 
 
Category 3 non – compliance 
 Failure to provide antiretroviral drugs of the pharmacological correct standards(example, poor 
quality generic equivalent) 
 
 
Stellenbosch University  http://scholar.sun.ac.za
67 
 
Category 4 non – compliance 
 Failure to initiate ARV’s appropriately. 
 Failure to provide proper, legible and understandable instructions with regard to medicine 
ingestion. 
(FPD, 2005:216) 
 
Looking at the classification of non –compliance, my research findings fall under category 1 non-
compliance, which are very serious. Research   studies have showed that most frequent reasons for 
missing doses were forgetting, sleeping through dosing time and not having medication at the time of 
prescribed dose.  
 
5.13 LIMITATIONS 
 
The study was done in two disciplines (Internal medicine-medical wards and Family medicine-primary 
health care wards). The  study  need to be extended to the whole Dr. George Mukhari hospital wards to 
have an overview of the whole institution regarding adherence to ARV treatment of hospitalized 
patients. 
 
There research results were not conclusive, measuring adherence is not easy without using other 
variables. The information from the patients might have been falsified because patients were 
interviewed once. The accurate data was from the audited files because there was no chance for health 
care workers to change or record additional information. They were not aware of what was checked. 
 
5.14 RECOMMENDATIONS 
 
The South African health system should respond to changes brought by emerging disease and patient 
involvement in their treatment plans. Watches should be displayed in the wards for patients to view the 
time. The government should move to the combined pill to reduce the burden of pills experienced by 
HIV positive patients on HAART. Adherence counselors are needed in the wards for patients support 
and continuous adherence counseling. This would not be difficult for Dr. George Mukhari hospital 
because Tuberculosis counselors are allocated in the wards for TB counseling. Standards need to be 
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developed so that every health care worker knows what is expected when taking care of patients on 
HAART. 
 
Training for HIV and AIDS management should be extended to all nurses, training should be included 
in their nursing training curriculum. There is also a great need to train health care providers about 
HIVTB collaboration and antiretroviral treatment. 
 
5.15 CONCLUSION 
 
Assessing medication adherence in general and ART in particular is difficult because of the need for 
longitudinal data. Literature reviewed mentioned this difficulty and even recommended a multi-
method approach for measuring ART adherence. According to (Steel G; 2005: 12),self reporting over 
estimate adherence, electronic monitoring is costly, requires technology capabilities and can 
underestimate adherence; pill counting can be falsified and impractical in busy clinic setting. Currently 
in South Africa HIV/AIDS guidelines rely upon pill counts which have been shown to overestimate 
adherence. 
 
Hospitalized patients on HAART really need 100% from nurses and doctors to promote continuous 
adherence to treatment. Patients that cited lack of privacy are those that did not disclose their HI 
positive status and ARV treatment. Disclosure it’s  a critical  element for patients to be free to take 
their treatment as prescribed. Health care workers need to adapt to changes and be flexible in their 
health care systems. Antiretroviral treatment are not the only treatment that challenged the routine 
schedule for giving treatment, the only factor is that the number of patients might be taxing to choose 
their treatment plan. 
 
According to literature studies, adherence to antiretroviral treatment is the powerful predictor of 
survival for individuals living with HIV and AIDS. There is a great need for HIV management training 
to increase staff knowledge and promote a positive relationship with admitted patients. 
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ANNEXURE:  A 
 
ANTRETROVIRAL DRUG ADHERENCE – HOSPITALIZED PATIENTS 
REGISTERED NURSES QUESTIONNAIRS [8 NURSES] 
1. How do you identify a patient on ARV’s? 
…………………………………………………………………………………………………………. 
 
2. Where do you keep individual’s ARV’s in the ward? 
 
……………………………………………………………………………………………………………
… 
 
3. Do you stick to individual’s treatment plan time when giving ARV.s 
 
……………………………………………………………………………………………………………
…. 
 
4. Are you trained with HIV/AIDS management? 
……………………………………………………………………………………………………………
………………… 
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RESPONSE FROM REGISTERED NURSES: 
1. Identifying a patient on ARV’s 
 When completing a nursing care plan a nurse should ask whether on any treatment. 
 These patients do not disclose their treatment because they were told it is confidential. 
 Other patients do tell us that they have treatment with them. 
 
2. Individual’s ARV kept 
 Kept in the medicine trolley and in the fridge [4 registered nurses]. 
 Patients prefer to keep them in their lockers or bags. 
 If the treatment is not prescribed, we tell patients to keep it and drink the way they were taught. 
 We are not sure of ARV side effects, we keep them next to the patients. 
 
3. Are they sticking to individual’s treatment plan 
 Patients have different times and we have staff shortage. 
 We give them according to routine medicine giving times, starting between 08:00 – 09:00[ 8 
registered nurses] 
 
4.Registered nurses interviewed and trained with HIV/AIDS  management 
 Two[2] registered nurses trained and well conversant about ARV patient management. 
 Registered nurses cited shortage of staff and rotation of staff that is trained moving to other wards. 
 Nursing managers not choosing appropriate people to go for training. 
 
5. Medicine given recorded in the nurses medicine sheet[25 files audited] 
 Only nine [9] files were recorded for ARV’s taken by patients. 
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ANNEXURE:  B 
ANTIRETROVIRAL DRUG ADHERENCE – HOSPITALIZED PATIENTS 
 
DOCTORS FILE AUDIT [25 PATIENT’S FILE] 
1. HIV status revealed or ARV treatment disclosed. 
 
YES                               NO 
 
2. ARV treatment prescribed. 
 
YES                                NO 
 
3. Plan written to send a consultation to an ARV clinic for further management of the patient. 
 
YES                               NO 
 
 
FINDINGS FROM PATIENT’S AUDITED FILES 25 files] 
 
1. Sixteen [16] files clinical notes reflected doctors writing that the patients are RVD positive and 
patients are on ARV treatment. 
 
2. Sixteen [16] files ARV prescribed. 
 
3. From other files doctors mentioned that the patient had treatment from home but did not review the 
ARV treatment. 
 
4. Doctors that reflected that the patients were on ARV treatment mentioned in their plan to send a 
consultation to an ARV clinic. 
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ANNEXURE:  C 
 
ANTIRETROVIRAL DRUG ADHERENCE – HOSPITALIZED PATIENTS 
 
PATIENTS QUESTINNAIRES 
1. How long are you on ARV’s? 
………………………………………………………………………………………… 
 
2.Do you remember the names of your ARV’s? 
Regimen 1(a)………………..Regimen 1(b)…………………Regimen 1(c )…………..Regimen 2 
 
3.What reminds to take your ARV’s on time? 
Cell…………….TV…………………Watch…………………Other 
 
If yes, what was the reason? 
……………………………………………………………………………………………………………
……….. 
 
4.Where are your ARV’s kept now that you are hospitalized? 
Nurses……………………………………………………………………………Locker/personal bag 
 
5.Have you ever taken your ARV’s late since admission? 
Yes…………………………………………………………………………………..No 
If yes, what was the reason? 
 
6. Have you missed your ARV’s since admission? 
Yes……………………………………………………..No 
If yes, how many did you miss? 
……………………………………………………………………………………………………… 
 
7. Did anyone ask you if you are on any treatment on admission? 
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Doctor……………………………………………………………Nurses 
 
8. Did you bring your ARV’s to the hospital? 
Yes……………………………………………………………No 
 
9. Have you disclosed your ARV’s to the nurses? 
Yes……………………………………………………………No 
 
10. Do you always take your ARV’s in the presence of other in-patients? 
Yes…………………………………………………………..No 
If no, what are the reasons? 
…………………………………………………………………………………………………………… 
 
Thank you for participating in the study. 
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ANNEXURE: D 
 
CONSENT FORM FOR THE PARTICIPANTS 
RESEARCH STUDY: 
Antiretroviral Drug Adherence – What happens when patients are hospitalized to medical wards and 
level one wards in Dr. George Mukhari hospital, and they are on Highly Active Antiretroviral Therapy 
(HAART). 
I have read information, the aims and the objectives of the proposed study. I have been given the 
opportunity t ask questions and given adequate time to rethink about it. I am satisfied about the 
answers to all my questions. The aims and the objectives of the study are sufficiently clear to me and I 
have not been pressurized to participate in any way. 
I do understand that participation in this study is voluntary, my records will be kept confidential and I 
may withdraw from the study at any time without giving reason. 
………………………………………………                                                             
……………………………… 
Name of the participant                                                                        Signature of the participant 
……………………………………………… 
Signature of the researcher 
………………………………………… 
Date 
RESEARCH DECLARATION 
I provided translation to the participant’s language verbally, the procedure and the potential benefits 
associated with participation in this research study. All questions asked by the individuals have been 
answered fully. 
…………………………………………………………                                   
……………………………………. 
Name of the researcher                                                            Date 
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ANNEXURE: E 
APPLICATION LETTER FOR THE PERMISSION TO CONDUCT THE RESEARCH 
STUDY 
 
1118 Block BB 
Soshanguve 
0152 
 
The Director  
Clinical Service 
Dr. George Mukhari Hospital 
Private Bag X422 
Pretoria 
0001 
 
Dear Sir/Madam 
Requesting permission to collect data for research at Level One and Medical Wards [Dr. George 
Mukhari Hospital] 
 
I hereby request a permission to collect data at the above mentioned wards for the research thesis. I am 
presently studying a Master of Philosophy (HIV/AIDS Management) with the University of 
Stellenbosch (African Centre of HIV/AIDS).My research topic will be about, 
Antiretroviral drug adherence – What happens when patients are hospitalized to medical wards and 
level one wards in Dr. George Mukhari hospital, and they are on Highly Active Antiretroviral Therapy 
[HAART]. 
 
Find attached a copy of my research proposal and permission from Stellenbosch University to conduct 
this research study 
 
Any questions concerning the study, you can contact the study Supervisor: Dr. Thozamile Qubuda, Tel 
no.:021-959 2615 E-mail:tqubuda@uwc.ac.za 
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Thank you 
T. H. Nkosi [HAST-Project Manager] 
Contact No: 012)529-3592 
Cell No: 076-9608474 
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